Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Relative Risk01:12

Relative Risk

1.7K
Relative risk (RR) is a statistical measure commonly used in epidemiology to compare the likelihood of a particular event occurring between two groups. This metric is important for evaluating the relationship between exposure to a specific risk factor and the probability of a particular outcome. It plays a crucial role in medical research, public health studies, and risk assessment. Relative risk quantifies how much more (or less) likely an event is to occur in an exposed group compared to an...
1.7K
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

380
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
380
Odds Ratio01:09

Odds Ratio

1.5K
The odds ratio (OR) is a statistical measure used extensively in epidemiology and research to quantify the strength of association between exposure and outcome across different groups. Unlike relative risk, which compares the probabilities of an event occurring, the odds ratio compares the odds of an event occurring in the exposed group to the odds of it occurring in the unexposed group. The odds, in this context, are calculated as the probability of the event happening divided by the...
1.5K
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

533
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
533
Hazard Ratio01:12

Hazard Ratio

549
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
549
Testing a Claim about Population Proportion01:24

Testing a Claim about Population Proportion

3.9K
A complete procedure for testing a claim about a population proportion is provided here.
There are two methods of testing a claim about a population proportion: (1) Using the sample proportion from the data where a binomial distribution is approximated to the normal distribution and (2) Using the binomial probabilities calculated from the data.
The first method uses normal distribution as an approximation to the binomial distribution. The requirements are as follows: sample size is large...
3.9K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Sample Size Recalculation in Adaptive Group Sequential Study Designs for Comparing Restricted Mean Survival Times.

Statistics in medicine·2026
Same author

Medial Unicompartmental Versus Total Knee Arthroplasty in the Treatment of Isolated Anteromedial Knee Osteoarthritis: Two-Year Results from a Double-Blinded, Multicenter, Randomized Trial of 350 Patients.

The Journal of bone and joint surgery. American volume·2026
Same author

Digital Health Intervention for and Long-Term Health Outcomes of a Divorce Cohort With Linked Danish Data: 5-Year Posttrial Follow-Up of a Randomized Controlled Trial.

Journal of medical Internet research·2025
Same author

Non-inferiority of Rituximab versus OCrelizumab in Multiple Sclerosis (ROC-MS)-an individual participant data meta-analysis.

Multiple sclerosis and related disorders·2025
Same author

Correction to "Propensity weighting plus adjustment in proportional hazards model is not doubly robust," by Erin E. Gabriel, Michael C. Sachs, Ingeborg Waernbaum, Els Goetghebeur, Paul F. Blanche, Stijn Vansteelandt, Arvid Sjölander, and Thomas Scheike; Volume 80, Issue 3, September 2024, https://doi.org/10.1093/biomtc/ujae069.

Biometrics·2025
Same author

Bystander Defibrillation and Survival According to Emergency Medical Service Response Time After Out-of-Hospital Cardiac Arrest: A Nationwide Registry-Based Cohort Study.

Prehospital emergency care·2025

相关实验视频

Updated: Jan 8, 2026

An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.5K

经验概率 绝对风险的比较

Paul Blanche1, Frank Eriksson1

  • 1Section of Biostatistics, University of Copenhagen, Copenhagen, Denmark.

Biometrical journal. Biometrische Zeitschrift
|December 18, 2025
PubMed
概括

本研究引入了一种经验概率方法,用于估计竞争性风险设置中的绝对风险. 这种方法提供了更准确的小样本推断和风险差异和风险比率之间的一致比较.

科学领域:

  • 生物统计学 生物统计学
  • 生存分析的分析.
  • 统计推理 统计推理

背景情况:

  • 在竞争性风险设置中,估计t年绝对风险或累积发病率函数至关重要.
  • 标准非参数的阿伦-约翰森估计器虽然对大样本具有强度,但在小样本性能方面存在局限性.
  • 不准确的信任区间覆盖和风险差异和风险比率之间的不一致结论是值得注意的问题.

研究的目的:

  • 引入一种替代的经验概率方法来估计竞争性风险中的绝对风险.
  • 为了解决小样本场景中Aalen-Johansen估计器的局限性.
  • 在使用风险差异和风险比率来比较绝对风险时,确保统计学意义结论的一致性.

主要方法:

  • 开发了一种经验概率方法,用于绝对风险估计.
  • 用于受约束的非参数最大概率估计 (NPMLE) 的衍生公式和算法.
  • 实施了R包"timeEL"中的新方法,以便在实践中应用.

主要成果:

  • 经验概率方法为风险差异和风险比率比较提供了一致的结论.
  • 与传统方法相比,模拟研究表明小样本推断的准确性有所提高.
  • 使用这种方法可以计算置信区间和p值,这些方法得到了非对称性属性的支持.
关键词:
审查 审查 审查竞争的风险竞争的风险.经验概率是经验概率.生存分析,生存分析.时间到事件数据.

更多相关视频

Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

10.7K
Measuring the Subjective Value of Risky and Ambiguous Options using Experimental Economics and Functional MRI Methods
13:04

Measuring the Subjective Value of Risky and Ambiguous Options using Experimental Economics and Functional MRI Methods

Published on: September 19, 2012

12.4K

相关实验视频

Last Updated: Jan 8, 2026

An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.5K
Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

10.7K
Measuring the Subjective Value of Risky and Ambiguous Options using Experimental Economics and Functional MRI Methods
13:04

Measuring the Subjective Value of Risky and Ambiguous Options using Experimental Economics and Functional MRI Methods

Published on: September 19, 2012

12.4K

结论:

  • 拟议的经验概率方法为绝对风险估计和竞争风险的比较提供了更可靠的替代方案.
  • 这种方法提高了在小样本大小的统计推理的准确性.
  • "timeEL" R包方便了这种方法的应用,通过骨髓移植数据分析证明了这一点.